Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 30:2021:7479423.
doi: 10.1155/2021/7479423. eCollection 2021.

The Current State of Parkinsonism in West Africa: A Systematic Review

Affiliations
Review

The Current State of Parkinsonism in West Africa: A Systematic Review

Jude T Quarshie et al. Parkinsons Dis. .

Abstract

Parkinsonism is one of the most common neurodegenerative diseases among the elderly. Africa is experiencing an increasing burden of age-related conditions including parkinsonism. However, there is not enough data on the prevalence, symptoms, and management of the disorder in West African patients. This systematic review examines the current state of parkinsonism in West Africa by discussing its epidemiology, symptomatology, and treatment. We searched PubMed, BioMed Central, and AJOL databases from January 2000 to December 2020 for studies on parkinsonism conducted in West African countries. We included 32 studies in this review: 23 from Nigeria, 5 from Ghana, and 1 each from Benin, Mali, Niger, and Senegal. Out of the 32 reviewed studies, 11 focused on the prevalence of parkinsonism, 4 examined the genetics of Parkinson's disease (PD), and 17 described the symptomatology and therapy of parkinsonism. The prevalence of parkinsonism in West Africa ranges from 6.0% to 8.3% of neurologic admissions/consultations. The estimated crude prevalence of PD in West Africa varies from 15 to 572 per 100,000 people. Thus far, no pathogenic genetic variants have been associated with PD in the region. Levodopa is frequently used singly or in combination with other medications to manage parkinsonian symptoms, which is consistent with reports from other African regions. Most of the reviewed studies focused only on PD, limiting assessment of other forms of parkinsonism. Almost all the prevalence studies were hospital-based and monocentric, making it impossible to accurately estimate the true prevalence of parkinsonism in West Africa. Larger community-based prevalence studies are recommended to enable accurate quantification of disease burden. Future genetic investigations should consider a wider array of gene mutations associated with parkinsonism. Moreover, public health surveillance strategies should be established to monitor the epidemiology of the disorder.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow diagram of literature search strategy and results.
Figure 2
Figure 2
West African countries are shown in shades of green. Yellow spots represent countries from which papers were obtained. (Image from www.conceptdraw.com).

Similar articles

Cited by

References

    1. Barbosa M. T., Caramelli P., Maia D. P., et al. Parkinsonism and Parkinson’s disease in the elderly: a community-based survey in Brazil (the bambuí study) Movement Disorders . 2006;21(6):800–808. doi: 10.1002/mds.20806. - DOI - PubMed
    1. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurology . 2018;17:939–953. - PMC - PubMed
    1. Iddi S., Li D., Aisen P. S., et al. Estimating the evolution of disease in the Parkinson’s progression markers initiative. Neurodegenerative Diseases . 2018;18(4):173–190. doi: 10.1159/000488780. - DOI - PMC - PubMed
    1. Oluwole O. G., Kuivaniemi H., Carr J. A., et al. Parkinson’s disease in Nigeria: a review of published studies and recommendations for future research. Parkinsonism & Related Disorders . 2019;62:36–43. doi: 10.1016/j.parkreldis.2018.12.004. - DOI - PMC - PubMed
    1. Shu L., Zhang Y., Sun Q., Pan H., Tang B. A comprehensive analysis of population differences in LRRK2 variant distribution in Parkinson’s disease. Frontiers in Aging Neuroscience . 2019;11(13) doi: 10.3389/fnagi.2019.00013. - DOI - PMC - PubMed

LinkOut - more resources